Valproic acid-associated pancytopenia: A dose-dependent adverse effect
Pancytopenia (PCP) is a life-threatening condition which is rarely associated with valproic acid (VPA). We present a case of an adult female with epilepsy that was seizure-free for the last three years. She was in use of VPA 500 mg bid. The subject reported that she recently had new seizures. VPA do...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2019-09-01
|
Series: | Romanian Journal of Neurology |
Subjects: | |
Online Access: | https://rjn.com.ro/articles/2019.3/RJN_2019_3_Art-09.pdf |